| Akcje insidera | 17 960 790 shares |
Wynik sentymentu insiderów
Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.
Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.
Częstotliwość aktualizacji: codziennie
Ocena sentymentu kadry kierowniczej
Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.
Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.
Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.
Częstotliwość aktualizacji: codziennie
Kluczowe wskaźniki insider
Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.
Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.
Liczba netto zakupów dokonanych przez insiderów (ranking)
N/A
Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).
Procent akcji kupowanych przez insiderów (ranking)
N/A
Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.
Wykres handlu insider
Poniższy wykres przedstawia Eiger BioPharmaceuticals, Inc. transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.
Lista insiderów i wskaźniki rentowności
Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|
Report errors via our new Insider Auditing Tool
Śledź historię zakupów insiderów — analiza zysków krótkoterminowych
W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w EIGR / Eiger BioPharmaceuticals, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Śledź historię sprzedaży insider — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w EIGR / Eiger BioPharmaceuticals, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia transakcji
Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.
| Plik Data |
Data transakcji |
Formularz | Wtajemniczony | Serce | Nazwa papieru wartościowego | Kod | Bezpośredni | Cena wykonania |
Cena jednostki |
Zmieniono jednostki |
Zmieniona wartość (1 tys.) |
Pozostałe opcje |
Pozostałe akcje |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-02 | 2023-11-02 | 4 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 0,2977 | 23 398 | 7 | 5 375 225 | ||||
| 2023-11-02 | 2023-11-01 | 4 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 0,2797 | 100 000 | 28 | 5 351 827 | ||||
| 2023-11-02 | 2023-10-31 | 4 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 0,2414 | 130 509 | 32 | 5 251 827 | ||||
| 2023-11-02 | 2023-10-31 | 4 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 0,2615 | 12 345 | 3 | 5 121 318 | ||||
| 2023-11-02 | 2023-10-31 | 4 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 0,2625 | 11 987 | 3 | 5 108 973 | ||||
| 2023-11-02 | 2023-10-31 | 4 | KAWAS LEEN See footnote. | EIGR | Common Stock | I | 0,2615 | 12 345 | 3 | 4 391 432 | ||||
| 2023-11-02 | 2023-10-31 | 4 | KAWAS LEEN See footnote. | EIGR | Common Stock | I | 0,2625 | 11 987 | 3 | 4 379 087 | ||||
| 2023-10-30 | 3 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 1 667 100 | ||||||||
| 2023-10-30 | 3 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 2 700 000 | ||||||||
| 2023-10-30 | 3 | KAYNE RICHARD A See footnote. | EIGR | Common Stock | I | 729 886 | ||||||||
| 2023-10-30 | 3 | KAWAS LEEN | EIGR | Common Stock | I | 1 667 100 | ||||||||
| 2023-10-30 | 3 | KAWAS LEEN | EIGR | Common Stock | I | 2 700 000 | ||||||||
| 2023-09-05 | 3 | Choong Ingrid By Family Trust | EIGR | Common Stock | I | 2 400 | ||||||||
| 2023-09-05 | 3 | Choong Ingrid | EIGR | Common Stock | D | 31 100 | ||||||||
| 2023-03-21 | 2023-03-17 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 1,0707 | -1 875 | -2 | 56 073 | ||||
| 2023-03-21 | 2023-03-17 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 1,0700 | -2 520 | -3 | 57 948 | ||||
| 2023-01-25 | 2023-01-23 | 4 | Dietz Thomas John By Trust | EIGR | Common Stock | I | 1,4316 | 50 000 | 72 | 50 000 | ||||
| 2023-01-03 | 2022-12-29 | 4 | Murray Christine | EIGR | Common Stock | D | 1,2208 | -5 000 | -6 | 11 000 | ||||
| 2022-12-27 | 2022-12-22 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 1,1690 | -22 500 | -26 | 21 000 | ||||
| 2022-12-27 | 2022-12-22 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 1,2795 | 100 000 | 128 | 182 355 | ||||
| 2022-08-18 | 2022-08-16 | 4 | Apelian David | EIGR | Common Stock | D | 9,8061 | -5 000 | -49 | 11 000 | ||||
| 2022-03-14 | 2022-03-14 | 4 | Ryali Sriram | EIGR | Common Stock | D | 5,5973 | -2 266 | -13 | 41 566 | ||||
| 2022-03-14 | 2022-03-14 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 5,5973 | -1 657 | -9 | 60 468 | ||||
| 2022-03-11 | 2022-03-11 | 4 | Loh Evan | EIGR | Stock Option (Right to Buy) | D | 5,10 | 12 000 | 12 000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Loh Evan | EIGR | Common Stock | D | 6 000 | 14 000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Atkisson Erik | EIGR | Stock Option (Right to Buy) | D | 5,10 | 38 000 | 38 000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Atkisson Erik | EIGR | Common Stock | D | 6 000 | 6 000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Mayer Eldon C. III | EIGR | Stock Option (Right to Buy) | D | 5,10 | 98 000 | 98 000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 16 000 | 62 125 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 5,10 | 12 000 | 12 000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Apelian David | EIGR | Common Stock | D | 6 000 | 16 000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Sablich Kim | EIGR | Stock Option (Right to Buy) | D | 5,10 | 12 000 | 12 000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Sablich Kim | EIGR | Common Stock | D | 6 000 | 6 000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Ryali Sriram | EIGR | Stock Option (Right to Buy) | D | 5,10 | 143 000 | 143 000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Ryali Sriram | EIGR | Common Stock | D | 24 000 | 43 832 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 5,10 | 12 000 | 12 000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 6 000 | 82 355 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 5,10 | 24 000 | 24 000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 6 000 | 43 500 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Sachdev Amit | EIGR | Stock Option (Right to Buy) | D | 5,10 | 12 000 | 12 000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Sachdev Amit | EIGR | Common Stock | D | 6 000 | 16 000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Murray Christine | EIGR | Stock Option (Right to Buy) | D | 5,10 | 12 000 | 12 000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Murray Christine | EIGR | Common Stock | D | 6 000 | 16 000 | ||||||
| 2022-03-11 | 2022-03-11 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 5,10 | 281 000 | 281 000 | |||||
| 2022-03-11 | 2022-03-11 | 4 | Cory David A | EIGR | Common Stock | D | 47 000 | 169 183 | ||||||
| 2022-01-11 | 2022-01-07 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 4,9501 | -1 560 | -8 | 46 125 | ||||
| 2021-10-01 | 2021-09-30 | 4 | Atkisson Erik | EIGR | Stock Option (Right to Buy) | D | 6,68 | 180 000 | 180 000 | |||||
| 2021-07-30 | 2021-07-29 | 4 | Mayer Eldon C. III | EIGR | Stock Option (Right to Buy) | D | 8,15 | 17 500 | 17 500 | |||||
| 2021-07-30 | 2021-07-29 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 8,15 | 48 750 | 48 750 | |||||
| 2021-07-30 | 2021-07-29 | 4 | Ryali Sriram | EIGR | Stock Option (Right to Buy) | D | 8,15 | 30 000 | 30 000 | |||||
| 2021-05-11 | 2021-05-10 | 4 | Ryali Sriram | EIGR | Stock Option (Right to Buy) | D | 8,49 | 87 000 | 87 000 | |||||
| 2021-04-23 | 2021-04-23 | 4 | Sablich Kim | EIGR | Stock Option (right to buy) | D | 8,43 | 25 000 | 25 000 | |||||
| 2021-04-12 | 2021-04-09 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 8,5000 | 1 000 | 8 | 37 500 | ||||
| 2021-04-12 | 2021-04-09 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 8,4800 | 1 500 | 13 | 36 500 | ||||
| 2021-03-15 | 2021-03-12 | 4 | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 9,99 | 71 250 | 71 250 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Shaffer James P | EIGR | Common Stock | D | 11 875 | 29 296 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Sachdev Amit | EIGR | Stock Option (Right to Buy) | D | 9,99 | 10 000 | 10 000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Sachdev Amit | EIGR | Common Stock | D | 5 000 | 10 000 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Ryali Sriram | EIGR | Stock Option (Right to Buy) | D | 9,99 | 97 500 | 97 500 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Ryali Sriram | EIGR | Common Stock | D | 16 250 | 18 152 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Patton Stephana Eilene | EIGR | Stock Option (Right to Buy) | D | 9,99 | 71 250 | 71 250 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Patton Stephana Eilene | EIGR | Common Stock | D | 11 875 | 17 948 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Murray Christine | EIGR | Stock Option (Right to Buy) | D | 9,99 | 10 000 | 10 000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Murray Christine | EIGR | Common Stock | D | 5 000 | 10 000 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Mayer Eldon C. III | EIGR | Stock Option (Right to Buy) | D | 9,99 | 71 250 | 71 250 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 11 875 | 47 685 | ||||||
| 2021-03-15 | 2021-03-15 | 4 | Loh Evan | EIGR | Common Stock | D | 10,1400 | -2 000 | -20 | 8 000 | ||||
| 2021-03-15 | 2021-03-12 | 4 | Loh Evan | EIGR | Stock Option (Right to Buy) | D | 9,99 | 10 000 | 10 000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Loh Evan | EIGR | Common Stock | D | 5 000 | 10 000 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 9,99 | 10 000 | 10 000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 5 000 | 76 355 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 9,99 | 20 000 | 20 000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 5 000 | 35 000 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 9,99 | 281 000 | 281 000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Cory David A | EIGR | Common Stock | D | 47 000 | 117 846 | ||||||
| 2021-03-15 | 2021-03-12 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 9,99 | 10 000 | 10 000 | |||||
| 2021-03-15 | 2021-03-12 | 4 | Apelian David | EIGR | Common Stock | D | 5 000 | 10 000 | ||||||
| 2021-01-11 | 2021-01-08 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 11,6800 | -1 690 | -20 | 35 810 | ||||
| 2020-08-12 | 2020-08-12 | 4 | Glenn Jeffrey S By spouse | EIGR | Common Stock | I | 11,4367 | 4 500 | 51 | 5 000 | ||||
| 2020-08-12 | 2020-08-12 | 4 | Glenn Jeffrey S By spouse | EIGR | Common Stock | I | 11,2750 | 500 | 6 | 500 | ||||
| 2020-08-12 | 2020-08-11 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 11,4927 | 5 000 | 57 | 71 355 | ||||
| 2020-03-17 | 2020-03-16 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 5,0271 | 30 000 | 151 | 66 355 | ||||
| 2020-03-17 | 2020-03-16 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 4,9500 | 1 000 | 5 | 30 000 | ||||
| 2020-03-13 | 2020-03-12 | 4 | Ryali Sriram | EIGR | Stock Option (Right to Buy) | D | 5,60 | 65 000 | 65 000 | |||||
| 2020-03-13 | 2020-03-05 | 4 | Ryali Sriram | EIGR | Common Stock | D | 7,3100 | 229 | 2 | 1 628 | ||||
| 2020-03-13 | 2020-03-12 | 4 | Sachdev Amit | EIGR | Stock Option (Right to Buy) | D | 5,60 | 10 000 | 10 000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Sachdev Amit | EIGR | Common Stock | D | 5 000 | 5 000 | ||||||
| 2020-03-13 | 2020-03-12 | 4 | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 5,60 | 50 000 | 50 000 | |||||
| 2020-03-13 | 2020-03-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 7,3100 | 1 500 | 11 | 15 921 | ||||
| 2020-03-13 | 2020-03-12 | 4 | Loh Evan | EIGR | Stock Option (Right to Buy) | D | 5,60 | 10 000 | 10 000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Loh Evan | EIGR | Common Stock | D | 5 000 | 5 000 | ||||||
| 2020-03-13 | 2020-03-12 | 4 | Murray Christine | EIGR | Stock Option (Right to Buy) | D | 5,60 | 10 000 | 10 000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Murray Christine | EIGR | Common Stock | D | 5 000 | 5 000 | ||||||
| 2020-03-13 | 2020-03-12 | 4 | Patton Stephana Eilene | EIGR | Stock Option (Right to Buy) | D | 5,60 | 65 000 | 65 000 | |||||
| 2020-03-13 | 2020-03-05 | 4 | Patton Stephana Eilene | EIGR | Common Stock | D | 7,3100 | 820 | 6 | 4 820 | ||||
| 2020-03-13 | 2020-03-12 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 5,60 | 10 000 | 10 000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Apelian David | EIGR | Common Stock | D | 5 000 | 5 000 | ||||||
| 2020-03-13 | 2020-03-12 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 5,60 | 20 000 | 20 000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 5 000 | 29 000 | ||||||
| 2020-03-13 | 2020-03-12 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 5,60 | 230 000 | 230 000 | |||||
| 2020-03-13 | 2020-03-05 | 4 | Cory David A | EIGR | Common Stock | D | 7,3100 | 1 500 | 11 | 69 346 | ||||
| 2020-03-13 | 2020-03-12 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 5,60 | 10 000 | 10 000 | |||||
| 2020-03-13 | 2020-03-12 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 5 000 | 36 355 | ||||||
| 2020-01-31 | 2020-01-31 | 4 | Mayer Eldon C. III | EIGR | Stock Option ( Right to Buy) | D | 12,36 | 150 000 | 150 000 | |||||
| 2020-01-31 | 2020-01-31 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 7 500 | 37 500 | ||||||
| 2020-01-30 | 2020-01-24 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 13,5205 | 5 000 | 68 | 30 000 | ||||
| 2020-01-13 | 2020-01-10 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 13,9400 | 4 000 | 56 | 24 000 | ||||
| 2019-09-06 | 2019-09-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 7,9475 | 1 500 | 12 | 14 421 | ||||
| 2019-09-06 | 2019-09-05 | 4 | Cory David A | EIGR | Common Stock | D | 7,9475 | 1 500 | 12 | 67 846 | ||||
| 2019-09-06 | 2019-09-05 | 4 | Ryali Sriram | EIGR | Common Stock | D | 9,3670 | 149 | 1 | 1 399 | ||||
| 2019-05-30 | 2019-05-30 | 4 | Sachdev Amit | EIGR | Stock Option ( Right to Buy) | D | 11,13 | 25 000 | 25 000 | |||||
| 2019-04-26 | 2019-02-04 | 4 | Cory David A | EIGR | Common Stock | D | 11,2600 | 343 | 4 | 66 346 | ||||
| 2019-04-23 | 2019-04-23 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 11,0990 | 5 000 | 55 | 20 000 | ||||
| 2019-04-22 | 2019-04-22 | 4 | Patton Stephana Eilene | EIGR | Common Stock | D | 11,0300 | 1 000 | 11 | 4 000 | ||||
| 2019-04-22 | 2019-04-22 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 11,0500 | 5 000 | 55 | 15 000 | ||||
| 2019-04-22 | 2019-04-22 | 4 | Ryali Sriram | EIGR | Common Stock | D | 11,0822 | 1 250 | 14 | 1 250 | ||||
| 2019-03-26 | 2019-03-21 | 4 | Apelian David | EIGR | Stock Option ( Right to Buy) | D | 14,31 | 110 500 | 110 500 | |||||
| 2019-03-26 | 2019-03-21 | 4 | Shaffer James P | EIGR | Stock Option ( Right to Buy) | D | 14,31 | 50 000 | 50 000 | |||||
| 2019-03-26 | 2019-03-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 7,9475 | 1 500 | 12 | 12 921 | ||||
| 2019-03-26 | 2018-09-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 7,9475 | 1 500 | 12 | 11 421 | ||||
| 2019-03-26 | 2018-03-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 8,0325 | 1 500 | 12 | 9 921 | ||||
| 2019-03-26 | 2017-09-05 | 4 | Shaffer James P | EIGR | Common Stock | D | 9,9025 | 1 500 | 15 | 8 421 | ||||
| 2019-03-26 | 2017-03-06 | 4 | Shaffer James P | EIGR | Common Stock | D | 8,2025 | 1 301 | 11 | 6 921 | ||||
| 2019-03-26 | 2019-03-21 | 4 | Murray Christine | EIGR | Stock Option ( Right to Buy) | D | 13,41 | 10 000 | 10 000 | |||||
| 2019-03-26 | 2019-03-21 | 4 | Cory David A | EIGR | Stock Option ( Right to Buy) | D | 14,31 | 200 000 | 200 000 | |||||
| 2019-03-26 | 2019-03-05 | 4 | Cory David A | EIGR | Common Stock | D | 7,9475 | 1 500 | 12 | 66 003 | ||||
| 2019-03-26 | 2018-09-05 | 4 | Cory David A | EIGR | Common Stock | D | 7,9475 | 1 500 | 12 | 64 503 | ||||
| 2019-03-26 | 2018-03-05 | 4 | Cory David A | EIGR | Common Stock | D | 8,0325 | 1 500 | 12 | 63 003 | ||||
| 2019-03-26 | 2017-09-05 | 4 | Cory David A | EIGR | Common Stock | D | 9,9025 | 1 500 | 15 | 61 503 | ||||
| 2019-03-26 | 2017-03-06 | 4 | Cory David A | EIGR | Common Stock | D | 8,2025 | 1 325 | 11 | 60 003 | ||||
| 2019-03-25 | 2019-03-21 | 4 | Loh Evan | EIGR | Stock Option ( Right to Buy) | D | 14,31 | 10 000 | 10 000 | |||||
| 2019-03-25 | 2019-03-21 | 4 | Glenn Jeffrey S | EIGR | Stock Option ( Right to Buy) | D | 14,31 | 10 000 | 10 000 | |||||
| 2019-03-25 | 2019-03-21 | 4 | Dietz Thomas John | EIGR | Stock Option ( Right to Buy) | D | 13,41 | 20 000 | 20 000 | |||||
| 2019-03-25 | 2019-03-21 | 4 | Mayer Eldon C. III | EIGR | Stock Option ( Right to Buy) | D | 13,41 | 10 000 | 10 000 | |||||
| 2019-03-25 | 3 | Patton Stephana Eilene | EIGR | Common Stock | D | 6 000 | ||||||||
| 2019-03-25 | 3 | Patton Stephana Eilene | EIGR | Common Stock | D | 6 000 | ||||||||
| 2019-03-25 | 3 | Patton Stephana Eilene | EIGR | Common Stock | D | 6 000 | ||||||||
| 2019-03-25 | 2019-03-21 | 4 | Patton Stephana Eilene | EIGR | Stock Option ( Right to Buy) | D | 14,31 | 90 000 | 90 000 | |||||
| 2019-02-06 | 2019-02-04 | 4 | Cory David A | EIGR | Common Stock | D | 14,1300 | 227 | 3 | 58 678 | ||||
| 2019-01-09 | 2019-01-07 | 4 | Murray Christine | EIGR | Stock Option ( Right to Buy) | D | 12,00 | 25 000 | 25 000 | |||||
| 2019-01-04 | 2019-01-03 | 4 | Ryali Sriram | EIGR | Stock Option ( Right to Buy) | D | 10,46 | 90 000 | 90 000 | |||||
| 2018-12-20 | 2018-12-20 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 9,9800 | 5 000 | 50 | 10 000 | ||||
| 2018-12-10 | 2018-12-06 | 4 | Dietz Thomas John | EIGR | Common Stock | D | 11,2600 | 5 000 | 56 | 5 000 | ||||
| 2018-11-30 | 2018-11-29 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 10,2100 | 4 000 | 41 | 25 000 | ||||
| 2018-11-28 | 2018-11-27 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 9,9210 | 7 500 | 74 | 15 000 | ||||
| 2018-11-28 | 2018-11-26 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 9,7524 | 7 500 | 73 | 7 500 | ||||
| 2018-11-28 | 2001-11-28 | 4 | Mayer Eldon C. III | EIGR | Common Stock | D | 10,0745 | 6 000 | 60 | 21 000 | ||||
| 2018-10-25 | 3 | RA Capital Healthcare Fund LP | EIGR | Common Stock | I | 4 830 916 | ||||||||
| 2018-10-25 | 3 | RA Capital Healthcare Fund LP | EIGR | Common Stock | I | 4 830 916 | ||||||||
| 2018-10-25 | 3 | RA Capital Healthcare Fund LP | EIGR | Common Stock | I | 4 830 916 | ||||||||
| 2018-10-25 | 3 | RA Capital Healthcare Fund LP | EIGR | Common Stock | I | 4 830 916 | ||||||||
| 2018-10-25 | 3 | RA Capital Healthcare Fund LP | EIGR | Common Stock | I | 4 830 916 | ||||||||
| 2018-10-22 | 2018-10-18 | 4 | INTERWEST PARTNERS X LP | EIGR | Common Stock | D | 12,0010 | -26 465 | -318 | 1 362 327 | ||||
| 2018-10-22 | 2018-10-18 | 4 | INTERWEST PARTNERS X LP | EIGR | Common Stock | D | 12,0717 | -210 800 | -2 545 | 1 388 792 | ||||
| 2018-04-04 | 2018-04-02 | 4 | Quan Joanne | EIGR | Stock Option (Right to Buy) | D | 2,06 | -4 000 | 22 256 | |||||
| 2018-04-04 | 2018-04-02 | 4 | Quan Joanne | EIGR | Common Stock | D | 10,0000 | -4 000 | -40 | 0 | ||||
| 2018-04-04 | 2018-04-02 | 4 | Quan Joanne | EIGR | Common Stock | D | 2,0600 | 4 000 | 8 | 4 000 | ||||
| 2018-03-16 | 2018-03-14 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 9,50 | 190 000 | 190 000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 9,50 | 37 000 | 37 000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 9,50 | 10 000 | 10 000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Mayer Eldon C. III | EIGR | Stock Option (Right to Buy) | D | 9,50 | 10 000 | 10 000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Loh Evan | EIGR | Stock Option (Right to Buy) | D | 9,50 | 10 000 | 10 000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 9,50 | 10 000 | 10 000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | WELCH JAMES H | EIGR | Stock Option (Right to Buy) | D | 9,50 | 60 000 | 60 000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Quan Joanne | EIGR | Stock Option (Right to Buy) | D | 9,50 | 60 000 | 60 000 | |||||
| 2018-03-16 | 2018-03-14 | 4 | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 9,50 | 60 000 | 60 000 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Mayer Eldon C. III | EIGR | Stock Option (right to buy) | D | 13,70 | 25 000 | 25 000 | |||||
| 2018-01-09 | 2018-01-05 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 13,70 | 150 000 | 150 000 | |||||
| 2017-10-06 | 2017-09-28 | 4 | Apelian David | EIGR | Stock Option (Right to Buy) | D | 10,75 | 25 000 | 25 000 | |||||
| 2017-09-18 | 2017-09-15 | 4 | Loh Evan | EIGR | Stock Option (Right to Buy) | D | 11,15 | 25 000 | 25 000 | |||||
| 2017-09-05 | 2017-09-01 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 9,5300 | 15 000 | 143 | 31 355 | ||||
| 2017-04-14 | 2017-04-12 | 4 | Kjellson Nina S | EIGR | Stock Option (Right to Buy) | D | 8,50 | 10 000 | 10 000 | |||||
| 2017-04-13 | 2017-04-12 | 4 | Bramlage Charles | EIGR | Stock Option (Right to Buy) | D | 8,50 | 10 000 | 10 000 | |||||
| 2017-04-13 | 2017-04-12 | 4 | ENGLEMAN EDGAR | EIGR | Stock Option (Right to Buy) | D | 8,50 | 10 000 | 10 000 | |||||
| 2017-04-13 | 2017-04-12 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 8,50 | 10 000 | 10 000 | |||||
| 2017-04-13 | 2017-04-12 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 8,50 | 10 000 | 10 000 | |||||
| 2017-03-14 | 2017-03-09 | 4 | Martins Eduardo Bruno | EIGR | Stock Option (Right to Buy) | D | 11,75 | 30 000 | 30 000 | |||||
| 2017-03-14 | 2017-03-09 | 4 | Quan Joanne | EIGR | Stock Option (Right to Buy) | D | 11,75 | 30 000 | 30 000 | |||||
| 2017-03-14 | 2017-03-09 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 11,75 | 133 000 | 133 000 | |||||
| 2017-03-14 | 2017-03-09 | 4 | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 11,75 | 40 000 | 40 000 | |||||
| 2017-03-14 | 2017-03-09 | 4 | WELCH JAMES H | EIGR | Stock Option (Right to Buy) | D | 11,75 | 40 000 | 40 000 | |||||
| 2016-11-21 | 2016-11-18 | 4 | Glenn Jeffrey S By son | EIGR | Common Stock | I | 12,9000 | 460 | 6 | 460 | ||||
| 2016-11-21 | 2016-11-17 | 4 | Glenn Jeffrey S | EIGR | Common Stock | D | 12,7300 | 15 000 | 191 | 16 355 | ||||
| 2016-09-15 | 2016-03-28 | 4/A | Bramlage Charles | EIGR | Stock Option (Right to Buy) | D | 15,75 | 25 000 | 25 000 | |||||
| 2016-09-15 | 2016-03-23 | 4/A | Cory David A | EIGR | Stock Option (Right to Buy) | D | 15,89 | 285 991 | 285 991 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 15,75 | 23 000 | 23 000 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 15,75 | 25 000 | 25 000 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 15,75 | 30 000 | 30 000 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 15,75 | 25 000 | 25 000 | |||||
| 2016-09-15 | 2016-03-23 | 4/A | Martins Eduardo Bruno | EIGR | Stock Option (Right to Buy) | D | 15,89 | 65 216 | 65 216 | |||||
| 2016-09-15 | 2016-03-23 | 4/A | Quan Joanne | EIGR | Stock Option (Right to Buy) | D | 15,89 | 53 452 | 53 452 | |||||
| 2016-09-15 | 2016-03-23 | 4/A | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 15,89 | 60 699 | 60 699 | |||||
| 2016-09-15 | 2016-03-23 | 4/A | WELCH JAMES H | EIGR | Stock Option (Right to Buy) | D | 15,89 | 57 571 | 57 571 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | ENGLEMAN EDGAR | EIGR | Stock Option (Right to Buy) | D | 15,75 | 25 000 | 25 000 | |||||
| 2016-09-15 | 2016-03-28 | 4/A | Kjellson Nina S | EIGR | Stock Option (Right to Buy) | D | 15,75 | 25 000 | 25 000 | |||||
| 2016-08-22 | 2016-08-18 | 4 | Vivo Ventures VI, LLC By Vivo Ventures VI Affiliates Fund, L.P. | EIGR | Common Stock | I | 16,0000 | 1 364 | 22 | 12 996 | ||||
| 2016-08-22 | 2016-08-18 | 4 | Vivo Ventures VI, LLC By Vivo Ventures Fund VI, L.P. | EIGR | Common Stock | I | 16,0000 | 186 136 | 2 978 | 1 774 096 | ||||
| 2016-08-19 | 2016-08-18 | 4 | Shaffer James P | EIGR | Common Stock | D | 15,7000 | 3 125 | 49 | 5 620 | ||||
| 2016-08-19 | 2016-08-18 | 4 | Cory David A | EIGR | Common Stock | D | 15,7000 | 1 562 | 25 | 58 451 | ||||
| 2016-06-22 | 2016-06-22 | 4 | WELCH JAMES H | EIGR | Common Stock | D | 19,7944 | 500 | 10 | 2 500 | ||||
| 2016-06-22 | 2016-06-20 | 4 | WELCH JAMES H | EIGR | Common Stock | D | 19,7962 | 2 000 | 40 | 2 000 | ||||
| 2016-06-14 | 2016-06-13 | 4 | Shaffer James P | EIGR | Common Stock | D | 22,2000 | 420 | 9 | 2 495 | ||||
| 2016-06-14 | 2016-06-13 | 4 | Shaffer James P | EIGR | Common Stock | D | 22,1700 | 100 | 2 | 2 075 | ||||
| 2016-06-14 | 2016-06-13 | 4 | Shaffer James P | EIGR | Common Stock | D | 22,1600 | 730 | 16 | 1 975 | ||||
| 2016-05-23 | 2016-05-23 | 4 | Shaffer James P | EIGR | Common Stock | D | 19,9900 | 745 | 15 | 1 245 | ||||
| 2016-05-23 | 2016-05-19 | 4 | Shaffer James P | EIGR | Common Stock | D | 19,5200 | 500 | 10 | 500 | ||||
| 2016-04-04 | 2016-03-28 | 4 | ENGLEMAN EDGAR | EIGR | Stock Option (Right to Buy) | D | 15,75 | 25 000 | 25 000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Bramlage Charles | EIGR | Stock Option (Right to Buy) | D | 15,75 | 25 000 | 25 000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Kjellson Nina S | EIGR | Stock Option (Right to Buy) | D | 15,75 | 25 000 | 25 000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 15,75 | 23 000 | 23 000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Dietz Thomas John | EIGR | Stock Option (Right to Buy) | D | 15,75 | 25 000 | 25 000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 15,75 | 30 000 | 30 000 | |||||
| 2016-04-01 | 2016-03-28 | 4 | Glenn Jeffrey S | EIGR | Stock Option (Right to Buy) | D | 15,75 | 25 000 | 25 000 | |||||
| 2016-03-31 | 3 | Kjellson Nina S By limited partnership | EIGR | Common Stock | I | 3 199 186 | ||||||||
| 2016-03-31 | 3 | Kjellson Nina S By limited partnership | EIGR | Common Stock | I | 3 199 186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3 199 186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3 199 186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3 199 186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3 199 186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3 199 186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3 199 186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3 199 186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3 199 186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3 199 186 | ||||||||
| 2016-03-31 | 3 | NASR KHALED | EIGR | Common Stock | D | 3 199 186 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 2 | EIGR | Common Stock | I | 1 611 224 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 1 | EIGR | Common Stock | I | 3 187 552 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 2 | EIGR | Common Stock | I | 1 611 224 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 1 | EIGR | Common Stock | I | 3 187 552 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 2 | EIGR | Common Stock | I | 1 611 224 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 2 | EIGR | Common Stock | I | 1 611 224 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 1 | EIGR | Common Stock | I | 3 187 552 | ||||||||
| 2016-03-28 | 3 | Vivo Ventures Fund VI, L.P. See footnote 1 | EIGR | Common Stock | I | 3 187 552 | ||||||||
| 2016-03-28 | 3 | Cory David A | EIGR | Common Stock | D | 144 128 | ||||||||
| 2016-03-28 | 3 | Cory David A | EIGR | Common Stock | D | 144 128 | ||||||||
| 2016-03-28 | 3 | Cory David A See footnote 1 | EIGR | Common Stock | I | 117 589 | ||||||||
| 2016-03-28 | 3 | Cory David A See footnote 1 | EIGR | Common Stock | I | 117 589 | ||||||||
| 2016-03-28 | 2016-03-23 | 4 | WELCH JAMES H | EIGR | Stock Option (Right to Buy) | D | 15,89 | 57 571 | 57 571 | |||||
| 2016-03-28 | 2016-03-23 | 4 | Shaffer James P | EIGR | Stock Option (Right to Buy) | D | 15,89 | 60 699 | 60 699 | |||||
| 2016-03-28 | 2016-03-23 | 4 | Cory David A | EIGR | Stock Option (Right to Buy) | D | 15,89 | 285 991 | 285 991 | |||||
| 2016-03-28 | 2016-03-23 | 4 | Quan Joanne | EIGR | Stock Option (Right to Buy) | D | 15,89 | 53 452 | 53 452 | |||||
| 2016-03-28 | 2016-03-23 | 4 | Martins Eduardo Bruno | EIGR | Stock Option (Right to Buy) | D | 15,89 | 65 216 | 65 216 | |||||
| 2016-03-25 | 3 | Glenn Jeffrey S | EIGR | Common Stock | I | 303 483 | ||||||||
| 2016-03-25 | 3 | Glenn Jeffrey S | EIGR | Common Stock | I | 303 483 | ||||||||
| 2016-03-25 | 3 | Glenn Jeffrey S | EIGR | Common Stock | D | 153 774 | ||||||||
| 2016-03-25 | 3 | Glenn Jeffrey S | EIGR | Common Stock | D | 153 774 | ||||||||
| 2016-03-25 | 3 | ENGLEMAN EDGAR See footnote 1 | EIGR | Common Stock | I | 3 187 552 | ||||||||
| 2016-03-25 | 3 | ENGLEMAN EDGAR See footnote 2 | EIGR | Common Stock | I | 1 611 224 | ||||||||
| 2016-03-25 | 3 | ENGLEMAN EDGAR See footnote 1 | EIGR | Common Stock | I | 3 187 552 | ||||||||
| 2016-03-25 | 3 | ENGLEMAN EDGAR See footnote 2 | EIGR | Common Stock | I | 1 611 224 | ||||||||
| 2015-06-30 | 3 | EcoR1 Capital, LLC See Note | CLDN | Common Stock | I | 5 686 340 | ||||||||
| 2015-06-30 | 3 | EcoR1 Capital, LLC See Note | CLDN | Common Stock | I | 5 686 340 | ||||||||
| 2015-06-05 | 2015-06-04 | 4 | Alton Gregg H | CLDN | Stock option (right to buy) | D | 2,16 | 10 000 | 40 000 | |||||
| 2015-06-05 | 2015-06-04 | 4 | NARACHI MICHAEL | CLDN | Stock option (right to buy) | D | 2,16 | 10 000 | 50 000 | |||||
| 2015-06-05 | 2015-06-04 | 4 | COOPER GRAHAM K | CLDN | Stock option (right to buy) | D | 2,16 | 10 000 | 40 000 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 2,16 | 10 000 | 22 800 | |||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 8,00 | -6 629 | 645 717 | |||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 1,12 | -41 302 | 652 346 | |||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 18,4400 | -6 629 | -122 | 3 125 | ||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 18,1600 | -41 302 | -750 | 9 754 | ||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 8,0000 | 6 629 | 53 | 51 056 | ||||
| 2015-04-07 | 2015-04-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 1,1200 | 41 302 | 46 | 44 427 | ||||
| 2015-04-03 | 2015-04-01 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 1,12 | -4 444 | 139 574 | |||||
| 2015-04-03 | 2015-04-01 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 19,1300 | -4 444 | -85 | 1 432 | ||||
| 2015-04-03 | 2015-04-01 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 1,1200 | 4 444 | 5 | 5 876 | ||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 8,00 | -1 012 | 150 726 | |||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 1,12 | -10 000 | 151 738 | |||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 16,9500 | -1 012 | -17 | 2 895 | ||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 17,3300 | -10 000 | -173 | 3 907 | ||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 8,0000 | 1 012 | 8 | 13 907 | ||||
| 2015-04-03 | 2015-04-02 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 1,1200 | 10 000 | 11 | 12 895 | ||||
| 2015-03-17 | 3 | Jackson Andrew C. | CLDN | Common Stock | D | 3 174 | ||||||||
| 2015-03-17 | 3 | Jackson Andrew C. | CLDN | Common Stock | D | 3 174 | ||||||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 8,00 | -6 629 | 693 648 | |||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 1,12 | -41 302 | 700 277 | |||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 24,7100 | -6 629 | -164 | 3 125 | ||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 24,8100 | -41 302 | -1 025 | 9 754 | ||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 8,0000 | 6 629 | 53 | 51 056 | ||||
| 2015-03-09 | 2015-03-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 1,1200 | 41 302 | 46 | 44 427 | ||||
| 2015-03-09 | 2015-03-06 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 9,58 | -5 000 | 12 800 | |||||
| 2015-03-09 | 2015-03-06 | 4 | Honig Peter | CLDN | Common Stock | D | 25,0000 | -5 000 | -125 | 0 | ||||
| 2015-03-09 | 2015-03-06 | 4 | Honig Peter | CLDN | Common Stock | D | 9,5800 | 5 000 | 48 | 5 000 | ||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 11,30 | -2 200 | 17 800 | |||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 11,30 | -2 500 | 20 000 | |||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Common Stock | D | 22,2900 | -2 200 | -49 | 0 | ||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Common Stock | D | 22,5000 | -2 500 | -56 | 2 200 | ||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Common Stock | D | 11,3000 | 2 200 | 25 | 4 700 | ||||
| 2015-03-09 | 2015-03-05 | 4 | Honig Peter | CLDN | Common Stock | D | 11,3000 | 2 500 | 28 | 2 500 | ||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 8,00 | -4 000 | 161 738 | |||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 1,12 | -10 000 | 165 738 | |||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 22,4800 | -4 000 | -90 | 2 895 | ||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 23,2900 | -10 000 | -233 | 6 895 | ||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 8,0000 | 4 000 | 32 | 16 895 | ||||
| 2015-03-09 | 2015-03-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 1,1200 | 10 000 | 11 | 12 895 | ||||
| 2015-03-03 | 2015-03-02 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 1,12 | -7 777 | 144 018 | |||||
| 2015-03-03 | 2015-03-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 18,4800 | -7 777 | -144 | 1 432 | ||||
| 2015-03-03 | 2015-03-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 1,1200 | 7 777 | 9 | 9 209 | ||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 8,00 | -4 000 | 175 738 | |||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 1,12 | -10 000 | 179 738 | |||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 16,0800 | -4 000 | -64 | 2 895 | ||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 16,0800 | -10 000 | -161 | 6 895 | ||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 8,0000 | 4 000 | 32 | 16 895 | ||||
| 2015-02-10 | 2015-02-06 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 1,1200 | 10 000 | 11 | 12 895 | ||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 8,00 | -6 629 | 741 579 | |||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 1,12 | -41 302 | 748 208 | |||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 15,9400 | -6 629 | -106 | 3 125 | ||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 15,8500 | -41 302 | -655 | 9 754 | ||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 8,0000 | 6 629 | 53 | 51 056 | ||||
| 2015-02-10 | 2015-02-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 1,1200 | 41 302 | 46 | 44 427 | ||||
| 2015-02-03 | 2015-02-02 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 1,12 | -7 777 | 151 795 | |||||
| 2015-02-03 | 2015-02-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 16,3500 | -7 777 | -127 | 1 432 | ||||
| 2015-02-03 | 2015-02-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 1,1200 | 7 777 | 9 | 9 209 | ||||
| 2015-01-12 | 2015-01-09 | 4 | RUDY JEFFREY J | CLDN | Stock option (right to buy) | D | 1,12 | -10 000 | 181 738 | |||||
| 2015-01-12 | 2015-01-09 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 18,5100 | -10 000 | -185 | 1 024 | ||||
| 2015-01-12 | 2015-01-09 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 1,1200 | 10 000 | 11 | 11 024 | ||||
| 2015-01-08 | 2015-01-06 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 1,12 | -41 302 | 789 510 | |||||
| 2015-01-08 | 2015-01-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 17,5100 | -41 302 | -723 | 3 125 | ||||
| 2015-01-08 | 2015-01-06 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 1,1200 | 41 302 | 46 | 44 427 | ||||
| 2015-01-08 | 2015-01-07 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 1,12 | -20 000 | 189 738 | |||||
| 2015-01-08 | 2015-01-07 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 17,3000 | -20 000 | -346 | 2 895 | ||||
| 2015-01-08 | 2015-01-07 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 1,1200 | 20 000 | 22 | 22 895 | ||||
| 2015-01-05 | 2015-01-02 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 1,12 | -7 777 | 159 572 | |||||
| 2015-01-05 | 2015-01-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 19,8800 | -7 777 | -155 | 1 432 | ||||
| 2015-01-05 | 2015-01-02 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 1,1200 | 7 777 | 9 | 9 209 | ||||
| 2015-01-05 | 2015-01-01 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 19,53 | -72 000 | 167 349 | |||||
| 2015-01-05 | 2015-01-01 | 4 | REED ELIZABETH E | CLDN | Stock option (right to buy) | D | 19,53 | 72 000 | 142 500 | |||||
| 2015-01-05 | 2015-01-01 | 4 | WIKLUND FREDRIK | CLDN | Stock option (right to buy) | D | 19,53 | 80 000 | 193 243 | |||||
| 2015-01-05 | 2015-01-01 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 19,53 | -80 000 | 209 738 | |||||
| 2015-01-05 | 2015-01-01 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 19,53 | -275 000 | 830 812 | |||||
| 2015-01-05 | 2015-01-01 | 4 | Cleveland Paul B | CLDN | Stock option (right to buy) | D | 19,53 | 140 000 | 417 500 | |||||
| 2015-01-05 | 2015-01-01 | 4 | RUDY JEFFREY J | CLDN | Stock option (right to buy) | D | 19,53 | -80 000 | 191 738 | |||||
| 2014-12-10 | 2014-12-09 | 4 | RUDY JEFFREY J | CLDN | Stock option (right to buy) | D | 1,12 | -10 000 | 111 738 | |||||
| 2014-12-10 | 2014-12-09 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 15,0000 | -10 000 | -150 | 414 | ||||
| 2014-12-10 | 2014-12-09 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 1,1200 | 10 000 | 11 | 10 414 | ||||
| 2014-12-10 | 2014-12-09 | 4 | ZSEBO KRISZTINA M | CLDN | Stock option (right to buy) | D | 1,12 | -41 302 | 555 812 | |||||
| 2014-12-10 | 2014-12-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 15,0000 | -41 302 | -620 | 1 531 | ||||
| 2014-12-10 | 2014-12-09 | 4 | ZSEBO KRISZTINA M | CLDN | Common Stock | D | 1,1200 | 41 302 | 46 | 42 833 | ||||
| 2014-12-08 | 2014-12-05 | 4 | LABA REBECQUE J | CLDN | Stock option (right to buy) | D | 1,12 | -20 000 | 129 738 | |||||
| 2014-12-08 | 2014-12-05 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 12,7700 | -20 000 | -255 | 691 | ||||
| 2014-12-08 | 2014-12-05 | 4 | LABA REBECQUE J | CLDN | Common Stock | D | 1,1200 | 20 000 | 22 | 20 691 | ||||
| 2014-12-02 | 2014-12-01 | 4 | TAKEYA RYAN K | CLDN | Stock option (right to buy) | D | 1,12 | -7 777 | 95 349 | |||||
| 2014-12-02 | 2014-12-01 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 12,0100 | -7 777 | -93 | 577 | ||||
| 2014-12-02 | 2014-12-01 | 4 | TAKEYA RYAN K | CLDN | Common Stock | D | 1,1200 | 7 777 | 9 | 8 354 | ||||
| 2014-11-18 | 2014-11-14 | 4 | RUDY JEFFREY J | CLDN | Stock option (right to buy) | D | 1,12 | -18 000 | 121 738 | |||||
| 2014-11-18 | 2014-11-14 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 11,6700 | -18 000 | -210 | 0 | ||||
| 2014-11-18 | 2014-11-14 | 4 | RUDY JEFFREY J | CLDN | Common Stock | D | 1,1200 | 18 000 | 20 | 18 000 | ||||
| 2014-06-20 | 3 | Cleveland Paul B | CLDN | No securities are beneficially owned | D | 0 | ||||||||
| 2014-06-20 | 2014-06-19 | 4 | Cleveland Paul B | CLDN | Stock option (right to buy) | D | 14,40 | 277 500 | 277 500 | |||||
| 2014-06-11 | 2014-06-09 | 4 | REED ELIZABETH E | CLDN | Stock option (right to buy) | D | 9,12 | 65 000 | 65 000 | |||||
| 2014-05-29 | 2014-05-28 | 4 | WIKLUND FREDRIK | CLDN | Stock option (right to buy) | D | 9,26 | 10 000 | 10 000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | Yang Patrick Y | CLDN | Stock option (right to buy) | D | 9,58 | 10 000 | 10 000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | Alton Gregg H | CLDN | Stock option (right to buy) | D | 9,58 | 10 000 | 10 000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | NARACHI MICHAEL | CLDN | Stock option (right to buy) | D | 9,58 | 10 000 | 10 000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | COOPER GRAHAM K | CLDN | Stock option (right to buy) | D | 9,58 | 10 000 | 10 000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 9,58 | 10 000 | 10 000 | |||||
| 2014-05-21 | 2014-05-20 | 4 | Funder Joshua | CLDN | Stock option (right to buy) | D | 9,58 | 10 000 | 10 000 | |||||
| 2014-03-20 | 2014-03-19 | 4 | LABA REBECQUE J | CLDN | Stock Option (Right to Buy) | D | 12,58 | 10 000 | 10 000 | |||||
| 2014-03-04 | 3 | Yang Patrick Y | CLDN | No securities are beneficially owned. | D | 0 | ||||||||
| 2014-03-04 | 2014-03-02 | 4 | Yang Patrick Y | CLDN | Stock option (right to buy) | D | 11,30 | 2 500 | 2 500 | |||||
| 2014-03-04 | 2014-03-02 | 4 | Yang Patrick Y | CLDN | Stock option (right to buy) | D | 11,30 | 10 000 | 10 000 | |||||
| 2014-03-04 | 3 | Honig Peter | CLDN | No securities are beneficially owned. | D | 0 | ||||||||
| 2014-03-04 | 2014-03-02 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 11,30 | 2 500 | 2 500 | |||||
| 2014-03-04 | 2014-03-02 | 4 | Honig Peter | CLDN | Stock option (right to buy) | D | 11,30 | 10 000 | 10 000 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Common Warrants | D | 5,61 | 25 481 | 25 481 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Series A-1 Preferred Warrants | D | 0,45 | -318 266 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Convertible Promissory Notes | D | 8,00 | 8,0000 | -16 537 | -132 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Series A-1 Convertible Preferred Stock | D | -17 146 250 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Common Stock | D | 8,0000 | 162 386 | 1 299 | 1 551 721 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Common Stock | D | 8,0000 | 16 537 | 132 | 1 389 335 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Novartis Bioventures Ltd | CLDN | Common Stock | D | 1 372 798 | 1 372 798 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | NARACHI MICHAEL | CLDN | Common Stock | D | 8,0000 | 62 500 | 500 | 62 500 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Warrant to Purchase Common Stock-Right to Buy | I | 5,61 | 17 517 | 17 517 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Warrant to Purchase Series A-1 Preferred Stock-Right to Buy | I | 0,45 | -218 806 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Convertible Promissory Notes | I | 8,00 | 8,0000 | -11 370 | -91 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Series A-1 Convertible Preferred Stock | I | -11 788 047 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Common Stock | I | 8,0000 | 111 608 | 893 | 1 066 775 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Common Stock | I | 8,0000 | 11 370 | 91 | 955 167 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Foley Todd | CLDN | Common Stock | I | 943 797 | 943 797 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Common Warrants | I | 5,61 | 20 833 | 20 833 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Series A-1 Preferred Warrants | I | 0,45 | -260 859 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Convertible Promissory Notes | I | 8,00 | 8,0000 | -13 553 | -108 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Junior Preferred Stock | I | -5 741 267 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Series A-1 Convertible Preferred Stock | I | -11 573 520 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Common Stock | I | 8,0000 | 133 083 | 1 065 | 1 950 184 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Common Stock | I | 8,0000 | 13 553 | 108 | 1 817 101 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partne | CLDN | Common Stock | I | 459 668 | 1 803 548 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Enterprise Partners Management LLC By entities affiliated with Enterprise Partners | CLDN | Common Stock | I | 926 621 | 1 343 880 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | WIKLUND FREDRIK | CLDN | Common Stock | D | 8,0000 | 20 000 | 160 | 20 000 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Common Warrants | I | 5,61 | 28 666 | 28 666 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Series A-1 Preferred Warrants | I | 0,45 | -358 049 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Convertible Promissory Notes | I | 8,00 | 8,0000 | -18 605 | -149 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Series A-1 Convertible Preferred Stock | I | -19 289 531 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Common Stock | I | 8,0000 | 182 681 | 1 461 | 1 745 683 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Common Stock | I | 8,0000 | 18 605 | 149 | 1 563 002 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Kordel Johan Lundbeckfond Invest A/S | CLDN | Common Stock | I | 1 544 397 | 1 544 397 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Common Warrants | D | 5,61 | 28 666 | 28 666 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Series A-1 Preferred Warrants | D | 0,45 | -358 049 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Convertible Promissory Notes | D | 8,00 | 8,0000 | -18 605 | -149 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Series A-1 Convertible Preferred Stock | D | -19 289 531 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Common Stock | D | 8,0000 | 182 681 | 1 461 | 1 745 683 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Common Stock | D | 8,0000 | 18 605 | 149 | 1 563 002 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Lundbeckfond Invest A/S | CLDN | Common Stock | D | 1 544 397 | 1 544 397 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Common Warrants | I | 5,61 | 53 807 | 53 807 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Series A-1 Preferred Warrants | I | 0,45 | -672 060 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Convertible Promissory Notes | I | 8,00 | 8,0000 | -23 145 | -185 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Series A-1 Convertible Preferred Stock | I | -11 788 047 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Common Stock | I | 8,0000 | 227 261 | 1 818 | 1 194 204 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Common Stock | I | 8,0000 | 23 145 | 185 | 966 943 | ||||
| 2014-02-06 | 2014-02-04 | 4 | Funder Joshua GBS Bioventures IV | CLDN | Common Stock | I | 943 798 | 943 798 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Common Warrants | D | 5,61 | 42 659 | 42 659 | |||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Series A-1 Preferred Warrants | D | 0,45 | -532 818 | 0 | |||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Convertible Promissory Notes | D | 8,00 | 8,0000 | -23 145 | -185 | 0 | |||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Series A-1 Convertible Preferred Stock | D | -19 289 531 | 0 | ||||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Common Stock | D | 8,0000 | 227 261 | 1 818 | 1 794 803 | ||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Common Stock | D | 8,0000 | 23 145 | 185 | 1 567 542 | ||||
| 2014-02-06 | 2014-02-04 | 4 | PFIZER INC | CLDN | Common Stock | D | 1 544 397 | 1 544 397 | ||||||
| 2014-01-29 | 3 | Enterprise Partners Liquidating Trust VI By entities affiliated with Enterprise Partners | CLDN | Common Stock | I | 417 259 |
P
Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych
S
Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych
A
Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)
C
Konwersja instrumentu pochodnego
D
Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki
F
Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki
G
Darowizna papierów wartościowych przez lub na rzecz insidera
K
Swapy kapitałowe i podobne transakcje zabezpieczające
M
Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)
V
Transakcja dobrowolnie zgłoszona na Formularzu 4
J
Inne (wraz z przypisem opisującym transakcję)
